A KPMG poll of 300+ investors shows more than half are looking to ramp up their acquisition activity.

Despite an environment of rising inflation and interest rates and with the possibility of a recession, 60 percent of healthcare and life sciences investors say they plan to increase their M&A activity in 2023.

The KMPG Healthcare and Life Sciences Investment Outlook sampled more than 300 executives on their perspective going into the new year and how that will affect their investment plans. For 2023, the theme seems to be strategic investments, as companies continue to combat continued supply chain issues, labor costs and inflation.

Read more on Healthcare Innovation here.